ClinVar Genomic variation as it relates to human health
NM_001972.4(ELANE):c.640G>A (p.Gly214Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001972.4(ELANE):c.640G>A (p.Gly214Arg)
Variation ID: 16748 Accession: VCV000016748.12
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 19p13.3 19: 856000 (GRCh38) [ NCBI UCSC ] 19: 856000 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 29, 2016 Mar 30, 2024 Mar 25, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001972.4:c.640G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001963.1:p.Gly214Arg missense NC_000019.10:g.856000G>A NC_000019.9:g.856000G>A NG_007274.1:g.1336G>A NG_009627.1:g.8710G>A LRG_46:g.1336G>A LRG_57:g.8710G>A LRG_57t1:c.640G>A P08246:p.Gly214Arg - Protein change
- G214R
- Other names
-
G185R
- Canonical SPDI
- NC_000019.10:855999:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ELANE | Little evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh38 GRCh37 |
557 | 600 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Mar 25, 2024 | RCV000018232.34 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jun 30, 2015 | RCV000214338.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Apr 27, 2018 | RCV001336413.1 | |
Pathogenic (1) |
criteria provided, single submitter
|
Sep 28, 2022 | RCV001851904.6 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jun 30, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000278970.9
First in ClinVar: May 29, 2016 Last updated: May 29, 2016 |
Comment:
The G214R missense mutation in the ELANE gene has been reported previously (as G185R) in association with congenital neutropenia (Dale et al., 2000; Bellanné-Chantelot et … (more)
The G214R missense mutation in the ELANE gene has been reported previously (as G185R) in association with congenital neutropenia (Dale et al., 2000; Bellanné-Chantelot et al., 2004). The G214R mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. (less)
|
|
Pathogenic
(Dec 20, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Neutropenia, severe congenital, 1, autosomal dominant
Affected status: yes
Allele origin:
de novo
|
Beijing Key Laboratry for Genetics of Birth Defects, Beijing Children's Hospital
Accession: SCV001499920.1
First in ClinVar: Sep 08, 2021 Last updated: Sep 08, 2021 |
Number of individuals with the variant: 1
Age: 0-9 years
Sex: female
Ethnicity/Population group: East Asia
Geographic origin: China
|
|
Pathogenic
(Apr 27, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Cyclical neutropenia
Affected status: yes
Allele origin:
de novo
|
Baylor Genetics
Accession: SCV001529791.1
First in ClinVar: Mar 22, 2021 Last updated: Mar 22, 2021 |
Comment:
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant was previously reported as disease-causing [PMID: 11001877, 15657182, 28073911, described … (more)
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant was previously reported as disease-causing [PMID: 11001877, 15657182, 28073911, described as p.G185R] (less)
|
|
Pathogenic
(May 08, 2023)
|
criteria provided, single submitter
Method: research
|
Neutropenia, severe congenital, 1, autosomal dominant
Affected status: yes
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV003924305.1
First in ClinVar: May 20, 2023 Last updated: May 20, 2023 |
|
|
Pathogenic
(Sep 28, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Neutropenia, severe congenital, 1, autosomal dominant
Cyclical neutropenia
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002238566.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 28, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly214 amino acid residue in ELANE. Other variant(s) that disrupt this … (more)
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly214 amino acid residue in ELANE. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23463630, 25427142). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this missense change affects ELANE function (PMID: 15657182, 28073911). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ELANE protein function. ClinVar contains an entry for this variant (Variation ID: 16748). This variant is also known as G185R. This missense change has been observed in individual(s) with clinical features of severe congenital neutropenia (PMID: 11001877, 16079102, 30386760). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 214 of the ELANE protein (p.Gly214Arg). (less)
|
|
Pathogenic
(Mar 25, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Neutropenia, severe congenital, 1, autosomal dominant
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV004801916.1
First in ClinVar: Mar 30, 2024 Last updated: Mar 30, 2024 |
Clinical Features:
Neutropenia (present) , Chronic neutropenia (present)
|
|
Pathogenic
(Jan 01, 2008)
|
no assertion criteria provided
Method: literature only
|
NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000038511.3
First in ClinVar: Apr 04, 2013 Last updated: Jul 21, 2018 |
Comment on evidence:
In patients with severe congenital neutropenia (SCN1; 202700), Dale et al. (2000) and Bellanne-Chantelot et al. (2004) identified a heterozygous 4924G-A transition in exon 5 … (more)
In patients with severe congenital neutropenia (SCN1; 202700), Dale et al. (2000) and Bellanne-Chantelot et al. (2004) identified a heterozygous 4924G-A transition in exon 5 of the ELA2 gene, resulting in a gly185-to-arg (G185R) substitution. Rosenberg et al. (2007) identified the G185R mutation in 4 of 82 unrelated patients with SCN1. Patients with the G185R mutation had a particularly severe disease course, and 2 developed MDS/AML at 10 and 15 years, respectively. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Clinical, Laboratory, and Molecular Characteristics and Remission Status in Children With Severe Congenital and Non-congenital Neutropenia. | Gong RL | Frontiers in pediatrics | 2018 | PMID: 30386760 |
A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA. | Qiu Y | The Journal of biological chemistry | 2017 | PMID: 28073911 |
The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. | Makaryan V | Current opinion in hematology | 2015 | PMID: 25427142 |
The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia. | Germeshausen M | Human mutation | 2013 | PMID: 23463630 |
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. | Rosenberg PS | British journal of haematology | 2008 | PMID: 18028488 |
A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. | Sera Y | Haematologica | 2005 | PMID: 16079102 |
Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. | Massullo P | Blood | 2005 | PMID: 15657182 |
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. | Bellanné-Chantelot C | Blood | 2004 | PMID: 14962902 |
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. | Dale DC | Blood | 2000 | PMID: 11001877 |
HIV risk (still) low for health care workers. | - | International nursing review | 1988 | PMID: 3229910 |
Text-mined citations for rs137854451 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.